Download PDF
Journal of Pediatric Neurology 2018; 16(05): 369-378
DOI: 10.1055/s-0038-1667004
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Encephalocraniocutaneous Lipomatosis (Haberland Syndrome or Fishman Syndrome)

Maria Teresa Garozzo
1   Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
,
Daniele Attardo
1   Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
,
Pierluigi Smilari
2   Unit of Clinical Pediatrics, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
,
Filippo Greco
2   Unit of Clinical Pediatrics, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
,
Agata Fiumara
2   Unit of Clinical Pediatrics, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
,
Agata Polizzi
3   Instiute of Neurological Science, National Research Council, Catania, Italy
,
Andrea D. Praticò
1   Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
4   Maurice Wohl Clinical Neuroscience Institute, King's College London, London, United Kingdom
,
Marina Mazzurco
1   Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
,
Concetta Pirrone
5   Section of Psychology, Department of Educational Sciences, University of Catania, Catania, Italy
,
Antonio Zanghì
6   Department of Medical and Surgical Sciences and Advanced Technology “G.F. Ingrassia,” University of Catania, Catania, Italy
,
Carmelo Schepis
7   Unit of Dermatology, Oasi Research Institute-IRCCS, Troina, Enna, Italy
,
Francesco Lacarrubba
8   Dermatology Clinic, University of Catania, Catania, Italy
,
Giuseppe Micali
8   Dermatology Clinic, University of Catania, Catania, Italy
,
Martino Ruggieri
1   Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
› Author Affiliations
Further Information

Publication History

23 May 2018

04 June 2018

Publication Date:
20 August 2018 (online)

    Permissions and Reprints

Abstract

Encephalocraniocutaneous lipomatosis is a sporadic, congenital neurocutaneous disorder characterized by the involvement of skin, central nervous system, and eye. A non-hereditary, autosomal mutation that may survive only in a mosaic state may be the cause of the clinical picture of the syndrome. Less than 80 patients have been so far reported and their clinical manifestations consisted of unilateral lipomatous hamartoma of the scalp or eyelid, epibulbar choristomas, and ipsilateral brain malformations. There is no clinical correlation between the severity of brain malformations and the clinical manifestations, and many patients with extremely extensive cerebral abnormalities are only minimal symptomatic. Seizures and mental retardation may also occur. The natural history is often favorable, without drug-resistant seizures and normal intelligence in most of the cases.

Keywords

encephalocraniocutaneous lipomatosis - Haberland syndrome - Fishman syndrome - epibulbar choristomas - brain malformations - seizures
 

  • References

  • 1 Ruggieri M, Polizzi A. From Aldrovandi's “Homuncio” (1592) to Buffon's girl (1749) and the “Wart Man” of Tilesius (1793): antique illustrations of mosaicism in neurofibromatosis?. J Med Genet 2003; 40 (03) 227-232
    CrossrefPubMedGoogle Scholar
  • 2 Ruggieri M, Praticò AD, Caltabiano R, Polizzi A. Rediagnosing one of Smith's patients (John McCann) with “neuromas tumours” (1849). Neurol Sci 2017; 38 (03) 493-499
    CrossrefPubMedGoogle Scholar
  • 3 Ruggieri M, Praticò AD, Scuderi A, Sorge G, Polizzi A. The multiple faces of artwork diagnoses. Lancet Neurol 2017; 16 (06) 417-418
    CrossrefPubMedGoogle Scholar
  • 4 Ruggieri M, Praticò AD, Caltabiano R, Polizzi A. Early history of the different forms of neurofibromatosis from ancient Egypt to the British Empire and beyond: first descriptions, medical curiosities, misconceptions, landmarks, and the persons behind the syndromes. Am J Med Genet A 2018; 176 (03) 515-550
    CrossrefPubMedGoogle Scholar
  • 5 Ruggieri M, Praticò AD, Serra A. , et al. Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms. Childs Nerv Syst 2017; 33 (04) 549-560
    CrossrefPubMedGoogle Scholar
  • 6 Haberland C, Perou M. Encephalocraniocutaneous lipomatosis. A new example of ectomesodermal dysgenesis. Arch Neurol 1970; 22 (02) 144-155
    CrossrefPubMedGoogle Scholar
  • 7 Fishman MA. Encephalocraniocutaneous lipomatosis. In: Roach ES, Miller Van S. . eds. Neurocutaneous Disorders, Cambridge, Cambridge University Press; 2004: 301-305
    Google Scholar
  • 8 Fishman MA. Encephalocraniocutaneous lipomatosis. J Child Neurol 1987; 2 (03) 186-193
    CrossrefPubMedGoogle Scholar
  • 9 Sanchez NP, Rhodes AR, Mandell F, Mihm MC. Encephalocraniocutaneous lipomatosis: a new neurocutaneous syndrome. Br J Dermatol 1981; 104 (01) 89-96
    CrossrefPubMedGoogle Scholar
  • 10 Lasierra R, Valencia I, Carapeto FJ. , et al. Encephalocraniocutaneous lipomatosis: neurologic manifestations. J Child Neurol 2003; 18 (10) 725-729
    CrossrefPubMedGoogle Scholar
  • 11 Miyao M, Saito T, Yamamoto Y, Kamoshita S. Encephalocraniocutaneous lipomatosis: a recently described neurocutaneous syndrome. Childs Brain 1984; 11 (04) 280-284
    PubMedGoogle Scholar
  • 12 Parazzini C, Triulzi F, Russo G, Mastrangelo M, Scotti G. Encephalocraniocutaneous lipomatosis: complete neuroradiologic evaluation and follow-up of two cases. Am J Neuroradiol 1999; 20 (01) 173-176
    PubMedGoogle Scholar
  • 13 Gaweł J, Schwartz RA, Józwiak S. Encephalocraniocutaneous lipomatosis. J Cutan Med Surg 2003; 7 (01) 61-65
    CrossrefPubMedGoogle Scholar
  • 14 Amor DJ, Kornberg AJ, Smith LJ. Encephalocraniocutaneous lipomatosis (Fishman syndrome): a rare neurocutaneous syndrome. J Paediatr Child Health 2000; 36 (06) 603-605
    CrossrefPubMedGoogle Scholar
  • 15 Brumback RA, Leech RW. Fishman's syndrome (encephalocraniocutaneous lipomatosis): a field defect of ectomesoderm. J Child Neurol 1987; 2 (03) 168-169
    CrossrefPubMedGoogle Scholar
  • 16 Sharifi M, Namdari M. Encephalocraniocutaneous lipomatosis (Fishman syndrome): a rare neurocutaneous syndrome. J Curr Ophthalmol 2016; 28 (03) 155-158
    CrossrefPubMedGoogle Scholar
  • 17 Romiti R, Rengifo JA, Arnone M, Sotto MN, Valente NY, Jansen T. Encephalocraniocutaneous lipomatosis: a new case report and review of the literature. J Dermatol 1999; 26 (12) 808-812
    CrossrefPubMedGoogle Scholar
  • 18 Happle R, Küster W. Nevus psiloliparus: a distinct fatty tissue nevus. Dermatology 1998; 197 (01) 6-10
    CrossrefPubMedGoogle Scholar
  • 19 Ruggieri M, Rizzo R, Pavone P, Babeli S, Sorge G, Happle R. Temporal triangular alopecia in a mother and her daughter associated with mental retardation and seizures. Arch Dermatol 2000; 136 (03) 426-427
    CrossrefPubMedGoogle Scholar
  • 20 Polizzi A, Pavone P, Ciancio E, La Rosa C, Sorge G, Ruggieri M. Hypertrichosis cubiti (hairy elbow syndrome): a clue to a malformation syndrome. J Pediatr Endocrinol Metab 2005; 18 (10) 1019-1025
    CrossrefPubMedGoogle Scholar
  • 21 Jóźwiak S, Gawel J, Kasprzyk-Obara J. , et al. Encephalocraniocutaneous lipomatosis - case report. Pediatr Pol 2001; 76: 53-56
    PubMedGoogle Scholar
  • 22 Hunter AG. Oculocerebrocutaneous and encephalocraniocutaneous lipomatosis syndromes: blind men and an elephant or separate syndromes?. Am J Med Genet A 2006; 140 (07) 709-726
    PubMedGoogle Scholar
  • 23 Grimalt R, Ermacora E, Mistura L. , et al. Encephalocraniocutaneous lipomatosis: case report and review of the literature. Pediatr Dermatol 1993; 10 (02) 164-168
    CrossrefPubMedGoogle Scholar
  • 24 Rubegni P, Risulo M, Sbano P, Buonocore G, Perrone S, Fimiani M. Encephalocraniocutaneous lipomatosis (Haberland syndrome) with bilateral cutaneous and visceral involvement. Clin Exp Dermatol 2003; 28 (04) 387-390
    CrossrefPubMedGoogle Scholar
  • 25 Sant'Anna GD, Saffer M, Mauri M, Facco S, Raupp S. Encephalocraniocutaneous lipomatosis with otolaryngologic manifestations: a rare neurocutaneous syndrome. Int J Pediatr Otorhinolaryngol 1999; 49 (03) 231-235
    CrossrefPubMedGoogle Scholar
  • 26 Banta J, Beasley K, Kobayashi T, Rohena L. Encephalocraniocutaneous lipomatosis (Haberland syndrome): a mild case with bilateral cutaneous and ocular involvement. JAAD Case Rep 2016; 2 (02) 150-152
    Google Scholar
  • 27 Happle R, Horster S. Nevus psiloliparus: report of two nonsyndromic cases. Eur J Dermatol 2004; 14 (05) 314-316
    PubMedGoogle Scholar
  • 28 Brown KE, Goldstein SM, Douglas RS, Katowitz JA. Encephalocraniocutaneous lipomatosis: a neurocutaneous syndrome. J AAPOS 2003; 7 (02) 148-149
    CrossrefPubMedGoogle Scholar
  • 29 Torrelo A, Boente MdelC, Nieto O. , et al Nevus psiloliparus and aplasia cutis: a further possible example of didymosis. Pediatr Dermatol 2005; 22 (03) 206-209
    CrossrefPubMedGoogle Scholar
  • 30 Ahmed I, Tope WD, Young TL, Miller DM, Bloom KE. Neurocutaneous melanosis in association with encephalocraniocutaneous lipomatosis. J Am Acad Dermatol 2002; 47 (2, Suppl): S196-S200
    CrossrefPubMedGoogle Scholar
  • 31 Jain P, Chakrabarty B, Kumar A, Gupta N, Kabra M, Gulati S. Encephalocraniocutaneous lipomatosis with neurocutaneous melanosis. J Child Neurol 2014; 29 (06) 846-849
    CrossrefPubMedGoogle Scholar
  • 32 Donaire A, Carreno M, Bargalló N. , et al. Presurgical evaluation and cognitive functional reorganization in Fishman syndrome. Epilepsy Behav 2005; 6 (03) 440-443
    CrossrefPubMedGoogle Scholar
  • 33 Matricardi S, Spalice A, Salpietro V. , et al. Epilepsy in the setting of full trisomy 18: a multicenter study on 18 affected children with and without structural brain abnormalities. Am J Med Genet C Semin Med Genet 2016; 172 (03) 288-295
    CrossrefPubMedGoogle Scholar
  • 34 Sorge G, Ruggieri M, Polizzi A, Scuderi A, Di Pietro M. SHORT syndrome: a new case with probable autosomal dominant inheritance. Am J Med Genet 1996; 61 (02) 178-181
    CrossrefPubMedGoogle Scholar
  • 35 Ruggieri M, Incorpora G, Polizzi A, Parano E, Spina M, Pavone P. Low prevalence of neurologic and psychiatric manifestations in children with gluten sensitivity. J Pediatr 2008; 152 (02) 244-249
    CrossrefPubMedGoogle Scholar
  • 36 Pavone P, Spalice A, Polizzi A, Parisi P, Ruggieri M. Ohtahara syndrome with emphasis on recent genetic discovery. Brain Dev 2012; 34 (06) 459-468
    CrossrefPubMedGoogle Scholar
  • 37 Ruggieri M, McShane MA. Parental view of epilepsy in Angelman syndrome: a questionnaire study. Arch Dis Child 1998; 79 (05) 423-426
    CrossrefPubMedGoogle Scholar
  • 38 Pavone P, Incorpora G, Fiumara A, Parano E, Trifiletti RR, Ruggieri M. Epilepsy is not a prominent feature of primary autism. Neuropediatrics 2004; 35 (04) 207-210
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Kim DH, Park SB, Lee Y. , et al. Encephalocraniocutaneous lipomatosis without neurologic anomalies. Ann Dermatol 2012; 24 (04) 476-478
    CrossrefPubMedGoogle Scholar
  • 40 Sofiatti A, Cirto AG, Arnone M. , et al. Encephalocraniocutaneous lipomatosis: clinical spectrum of systemic involvement. Pediatr Dermatol 2006; 23 (01) 27-30
    CrossrefPubMedGoogle Scholar
  • 41 Polizzi A, Pavone P, Parano E, Incorpora G, Ruggieri M. Lack of progression of brain atrophy in Aicardi-Goutières syndrome. Pediatr Neurol 2001; 24 (04) 300-302
    CrossrefPubMedGoogle Scholar
  • 42 Polizzi A, Coghill S, McShane MA, Squier W. Acute ataxia complicating Langerhans cell histiocytosis. Arch Dis Child 2002; 86 (02) 130-131
    CrossrefPubMedGoogle Scholar
  • 43 O'Connor KC, Lopez-Amaya C, Gagne D. , et al. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis. J Neuroimmunol 2010; 223 (1–2): 92-99
    CrossrefPubMedGoogle Scholar
  • 44 Salpietro V, Polizzi A, Bertè LF. , et al. Idiopathic intracranial hypertension: a unifying neuroendocrine hypothesis through the adrenal-brain axis. Neuroendocrinol Lett 2012; 33 (06) 569-573
    PubMedGoogle Scholar
  • 45 Salpietro V, Polizzi A, Di Rosa G. , et al. Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications. Int J Endocrinol 2014; 2014: 282489
    CrossrefPubMedGoogle Scholar
  • 46 Salpietro V, Mankad K, Kinali M. , et al. Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study. J Pediatr Endocrinol Metab 2014; 27 (1–2(: 107-115
    CrossrefPubMedGoogle Scholar
  • 47 Pavone P, Pettoello-Mantovano M, Le Pira A. , et al. Acute disseminated encephalomyelitis: a long-term prospective study and meta-analysis. Neuropediatrics 2010; 41 (06) 246-255
    Article in Thieme ConnectPubMedGoogle Scholar
  • 48 Moog U, Jones MC, Bird LM, Dobyns WB. Oculocerebrocutaneous syndrome: the brain malformation defines a core phenotype. J Med Genet 2005; 42 (12) 913-921
    CrossrefPubMedGoogle Scholar
  • 49 Nowaczyk MJ, Mernagh JR, Bourgeois JM, Thompson PJ, Jurriaans E. Antenatal and postnatal findings in encephalocraniocutaneous lipomatosis. Am J Med Genet 2000; 91 (04) 261-266
    CrossrefPubMedGoogle Scholar
  • 50 Chittenden HB, Harman KE, Robinson F, Higgins EM. A case of encephalocraniocutaneous lipomatosis. Br J Ophthalmol 2002; 86 (08) 934-935
    CrossrefPubMedGoogle Scholar
  • 51 Nosti-Martínez D, del Castillo V, Durán-Mckinster C, Tamayo-Sánchez L, Orozco-Covarrubias ML, Ruiz-Maldonado R. Encephalocraniocutaneous lipomatosis: an uncommon neurocutaneous syndrome. J Am Acad Dermatol 1995; 32 (2 Pt 2): 387-389
    CrossrefPubMedGoogle Scholar
  • 52 Moog U, Jones MC, Viskochil DH, Verloes A, Van Allen MI, Dobyns WB. Brain anomalies in encephalocraniocutaneous lipomatosis. Am J Med Genet A 2007; 143A (24) 2963-2972
    CrossrefPubMedGoogle Scholar
  • 53 Lee RK, Lui PP, Tong CS, Chu WC. Encephalocraniocutaneous lipomatosis: a rare case with development of diffuse leptomeningeal lipomatosis during childhood. Pediatr Radiol 2012; 42 (01) 129-133
    CrossrefPubMedGoogle Scholar
  • 54 Chandravanshi SL. Encephalocraniocutaneous lipomatosis: a case report and review of the literature. Indian J Ophthalmol 2014; 62 (05) 622-627
    CrossrefPubMedGoogle Scholar
  • 55 Almer Z, Vishnevskia-Dai V, Zadok D. Encephalocraniocutaneous lipomatosis: case report and review of the literature. Cornea 2003; 22 (04) 389-390
    CrossrefPubMedGoogle Scholar
  • 56 Valladares MJ, Blanco MJ, Lopez-Lopez F, Gonzalez F. Bilateral ocular involvement in encephalocraniocutaneous lipomatosis. Eur J Paediatr Neurol 2007; 11 (02) 108-110
    PubMedGoogle Scholar
  • 57 Ruggieri M, Pavone V, Polizzi A. , et al. Tuberculosis of the ankle in childhood: clinical, roentgenographic and computed tomography findings. Clin Pediatr (Phila) 1997; 36 (09) 529-534
    CrossrefPubMedGoogle Scholar
  • 58 Lionetti E, Francavilla R, Maiuri L. , et al. Headache in pediatric patients with celiac disease and its prevalence as a diagnostic clue. J Pediatr Gastroenterol Nutr 2009; 49 (02) 202-207
    CrossrefPubMedGoogle Scholar
  • 59 Ruggieri M, Pavone V, De Luca D, Franzò A, Tiné A, Pavone L. Congenital bone malformations in patients with neurofibromatosis type 1 (Nf1). J Pediatr Orthop 1999; 19 (03) 301-305
    CrossrefPubMedGoogle Scholar
  • 60 Andreadis DA, Rizos CB, Belazi M, Peneva M, Antoniades DZ. Encephalocraniocutaneous lipomatosis accompanied by maxillary compound odontoma and juvenile angiofibroma: report of a case. Birth Defects Res A Clin Mol Teratol 2004; 70 (11) 889-891
    CrossrefPubMedGoogle Scholar
  • 61 Savage MG, Heldt L, Dann JJ, Bump RL. Encephalocraniocutaneous lipomatosis and mixed odontogenic tumors. J Oral Maxillofac Surg 1985; 43 (08) 617-620
    CrossrefPubMedGoogle Scholar
  • 62 Zielińska-Kaźmierska B, Grodecka J, Jabłońska-Polakowska L, Arkuszewski P. Mandibular osteoma in the encephalocraniocutaneous lipomatosis. J Craniomaxillofac Surg 2005; 33 (04) 286-289
    CrossrefPubMedGoogle Scholar
  • 63 MacLaren MJ, Kluijt I, Koole FD. Ophthalmologic abnormalities in encephalocraniocutaneous lipomatosis. Doc Ophthalmol 1995; 90 (01) 87-98
    CrossrefPubMedGoogle Scholar
  • 64 Delfino LN, Fariello G, Quattrocchi CC. , et al. Encephalocraniocutaneous lipomatosis (ECCL): neuroradiological findings in three patients and a new association with fibrous dysplasia. Am J Med Genet A 2011; 155A (07) 1690-1696
    PubMedGoogle Scholar
  • 65 Spalice A, Ruggieri M, Grosso S. , et al. Dysembryoplastic neuroepithelial tumors: a prospective clinicopathologic and outcome study of 13 children. Pediatr Neurol 2010; 43 (06) 395-402
    CrossrefPubMedGoogle Scholar
  • 66 Moog U. Encephalocraniocutaneous lipomatosis. J Med Genet 2009; 46 (11) 721-729
    CrossrefPubMedGoogle Scholar
  • 67 Ruggieri M, Iannetti P, Pavone L. Delineation of a newly recognized neurocutaneous malformation syndrome with “cutis tricolor.”. Am J Med Genet A 2003; 120A (01) 110-116
    CrossrefPubMedGoogle Scholar
  • 68 Ruggieri M, Iannetti F, Polizzi A. , et al. Cataracts in the setting of a newly recognised neurocutaneous malformation syndrome with cutis tricolor. Br J Ophthalmol 2009; 93: 175-176
    PubMedGoogle Scholar
  • 69 Ruggieri M, Roggini M, Kennerknecht I, Polizzi A, Distefano A, Pavone V. Spectrum of skeletal abnormalities in a complex malformation syndrome with “cutis tricolor” (Ruggieri-Happle syndrome). Acta Paediatr 2011; 100 (01) 121-127
    CrossrefPubMedGoogle Scholar
  • 70 Nicita F, Spalice A, Roggini M. , et al. Complex malformation (Ruggieri-Happle) phenotype with “cutis tricolor” in a 10-year-old girl. Brain Dev 2012; 34 (10) 869-872
    CrossrefPubMedGoogle Scholar
  • 71 Ruggieri M, Polizzi A, Schepis C. , et al. Cutis tricolor: a literature review and report of five new cases. Quant Imaging Med Surg 2016; 6 (05) 525-534
    CrossrefPubMedGoogle Scholar
  • 72 Lionetti E, Pavone P, Kennerknecht I. , et al. Neurological manifestations in individuals with pure cutaneous or syndromic (Ruggieri-Happle syndrome) phenotypes with “cutis tricolor”: a study of 14 cases. Neuropediatrics 2010; 41 (02) 60-65
    Article in Thieme ConnectPubMedGoogle Scholar
  • 73 Papetti L, Tarani L, Nicita F. , et al. Macrocephaly-capillary malformation syndrome: description of a case and review of clinical diagnostic criteria. Brain Dev 2012; 34 (02) 143-147
    CrossrefPubMedGoogle Scholar
  • 74 Ruggieri M, Milone P, Pavone P. , et al. Nevus vascularis mixtus (cutaneous vascular twin nevi) associated with intracranial vascular malformation of the Dyke-Davidoff-Masson type in two patients. Am J Med Genet A 2012; 158A (11) 2870-2880
    CrossrefPubMedGoogle Scholar
  • 75 Ruggieri M, Polizzi A, Strano S. , et al. Mixed vascular nevus syndrome: a report of four new cases and a literature review. Quant Imaging Med Surg 2016; 6 (05) 515-524
    CrossrefPubMedGoogle Scholar
  • 76 Barbagallo M, Ruggieri M, Incorpora G. , et al. Infantile spasms in the setting of Sturge-Weber syndrome. Childs Nerv Syst 2009; 25 (01) 111-118
    CrossrefPubMedGoogle Scholar
  • 77 Ruggieri M, D'Arrigo G, Abbate M, Distefano A, Upadhyaya M. Multiple coronary artery aneurysms in a child with neurofibromatosis type 1. Eur J Pediatr 2000; 159 (07) 477-480
    CrossrefPubMedGoogle Scholar
  • 78 Ruggieri M, Packer RJ. Why do benign astrocytomas become malignant in NF1?. Neurology 2001; 56 (07) 827-829
    CrossrefPubMedGoogle Scholar
  • 79 Ruggieri M, Polizzi A. Choroidal abnormalities and mental retardation in neurofibromatosis type 1. Lancet 2001; 357 (9252): 311-312
    PubMedGoogle Scholar
  • 80 Ruggieri M, Pavone V, Tiné A. , et al. Ossifying fibroma of the skull in a patient with neurofibromatosis type 1. Case report. J Neurosurg 1996; 85 (05) 941-944
    CrossrefPubMedGoogle Scholar
  • 81 Hamm H. Cutaneous mosaicism of lethal mutations. Am J Med Genet 1999; 85 (04) 342-345
    CrossrefPubMedGoogle Scholar
  • 82 Cultrera F, Guarnera F, Giardina MC. Overlap among neurocutaneous syndromes. Observations on encephalocraniocutaneous lipomatosis. Minerva Pediatr 2004; 56 (02) 219-222
    PubMedGoogle Scholar
  • 83 Legius E, Wu R, Eyssen M, Marynen P, Fryns JP, Cassiman JJ. Encephalocraniocutaneous lipomatosis with a mutation in the NF1 gene. J Med Genet 1995; 32 (04) 316-319
    CrossrefPubMedGoogle Scholar
  • 84 Prontera P, Stangoni G, Manes I, Mencarelli A, Donti E. Encephalocraniocutaneous lipomatosis (ECCL) in a patient with history of familial multiple lipomatosis (FML). Am J Med Genet A 2009; 149A (03) 543-545
    CrossrefPubMedGoogle Scholar
  • 85 Bennett JT, Tan TY, Alcantara D. , et al; University of Washington Center for Mendelian Genomics; Care4Rare Canada Consortium. Mosaic activating mutations in FGFR1 cause encephalocraniocutaneous lipomatosis. Am J Hum Genet 2016; 98 (03) 579-587
    CrossrefPubMedGoogle Scholar
  • 86 Boppudi S, Bögershausen N, Hove HB. , et al. Specific mosaic KRAS mutations affecting codon 146 cause oculoectodermal syndrome and encephalocraniocutaneous lipomatosis. Clin Genet 2016; 90 (04) 334-342
    CrossrefPubMedGoogle Scholar
  • 87 Koishi GN, Yoshida M, Alonso N, Matushita H, Goldenberg D. Encephalocraniocutaneous lipomatosis (Haberland's syndrome): a case report of a neurocutaneous syndrome and a review of the literature. Clinics (Sao Paulo) 2008; 63 (03) 406-408
    CrossrefPubMedGoogle Scholar
  • 88 Ruggieri M, Praticò AD. Mosaic neurocutaneous disorders and their causes. Semin Pediatr Neurol 2015; 22 (04) 207-233
    CrossrefPubMedGoogle Scholar
  • 89 McCall S, Ramzy MI, Curé JK, Pai GS. Encephalocraniocutaneous lipomatosis and the Proteus syndrome: distinct entities with overlapping manifestations. Am J Med Genet 1992; 43 (04) 662-668
    CrossrefPubMedGoogle Scholar
  • 90 Rizzo R, Pavone L, Micali G, Nigro F, Cohen Jr MM. Encephalocraniocutaneous lipomatosis, Proteus syndrome, and somatic mosaicism. Am J Med Genet 1993; 47 (05) 653-655
    CrossrefPubMedGoogle Scholar
  • 91 Wiedemann HR, Burgio GR. Encephalocraniocutaneous lipomatosis and Proteus syndrome. Am J Med Genet 1986; 25 (02) 403-404
    CrossrefPubMedGoogle Scholar
  • 92 Al-Mefty O, Fox JL, Sakati N, Bashir R, Probst F. The multiple manifestations of the encephalocraniocutaneous lipomatosis syndrome. Childs Nerv Syst 1987; 3 (02) 132-134
    CrossrefPubMedGoogle Scholar
  • 93 Bamforth JS, Riccardi VM, Thisen P. , et al. Encephalocraniocutaneous lipomatosis. Report of two cases and a review of the literature. Neurofibromatosis 1989; 2 (03) 166-173
    PubMedGoogle Scholar
  • 94 Schlack HG, Skopnik H. Encephalocraniocutaneous lipomatosis and linear naevus sebaceus [Article in German]. Monatsschr Kinderheilkd 1985; 133 (04) 235-237
    PubMedGoogle Scholar
  • 95 Narbay G, Meire F, Verloes A, Casteels I, Devos E. Ocular manifestations in Delleman syndrome (Oculocerebrocutaneous syndrome, OCC-syndrome) and encephalocraniocutaneous lipomatosis (ECCL). Report of three cases. Bull Soc Belge Ophtalmol 1996; 261: 65-70
    PubMedGoogle Scholar
  • 96 Moog U, de Die-Smulders C, Systermans JM, Cobben JM. Oculocerebrocutaneous syndrome: report of three additional cases and aetiological considerations. Clin Genet 1997; 52 (04) 219-225
    PubMedGoogle Scholar
  • 97 Kodsi SR, Bloom KE, Egbert JE, Holland EJ, Cameron JD. Ocular and systemic manifestations of encephalocraniocutaneous lipomatosis. Am J Ophthalmol 1994; 118 (01) 77-82
    CrossrefPubMedGoogle Scholar
  • 98 Goltz RW. Focal dermal hypoplasia syndrome. An update. Arch Dermatol 1992; 128 (08) 1108-1111
    CrossrefPubMedGoogle Scholar
  • 99 Hardman CM, Garioch JJ, Eady RA, Fry L. Focal dermal hypoplasia: report of a case with cutaneous and skeletal manifestations. Clin Exp Dermatol 1998; 23 (06) 281-285
    CrossrefPubMedGoogle Scholar
  • 100 Ardinger HH, Horii KA, Begleiter ML. Expanding the phenotype of oculoectodermal syndrome: possible relationship to encephalocraniocutaneous lipomatosis. Am J Med Genet A 2007; 143A (24) 2959-2962
    CrossrefPubMedGoogle Scholar
  • 101 Moog U, Roelens F, Mortier GR. , et al. Encephalocraniocutaneous lipomatosis accompanied by the formation of bone cysts: harboring clues to pathogenesis?. Am J Med Genet A 2007; 143A (24) 2973-2980
    CrossrefPubMedGoogle Scholar
  • 102 Toriello HV, Bultman R, Panek RW. , et al. Non-ossifying fibromas and giant cell reparative granulomas in a child with ocular-ectodermal syndrome. Clin Dysmorphol 1999; 8 (04) 265-268
    PubMedGoogle Scholar
  • 103 Federici S, Griffiths D, Siberchicot F, Chateil J-F, Gilbert B, Lacombe D. Oculo-ectodermal syndrome: a new tumour predisposition syndrome. Clin Dysmorphol 2004; 13 (02) 81-83
    CrossrefPubMedGoogle Scholar
  • 104 Pavone L, Curatolo P, Rizzo R. , et al. Epidermal nevus syndrome: a neurologic variant with hemimegalencephaly, gyral malformation, mental retardation, seizures, and facial hemihypertrophy. Neurology 1991; 41 (2 Pt 1): 266-271
    CrossrefPubMedGoogle Scholar
  • 105 Mall V, Heinen F, Uhl M, Wellens E, Korinthenberg R. CNS lipoma in patients with epidermal nevus syndrome. Neuropediatrics 2000; 31 (04) 175-179
    Article in Thieme ConnectPubMedGoogle Scholar
  • 106 Booth TN, Rollins NK. MR imaging of the spine in epidermal nevus syndrome. AJNR Am J Neuroradiol 2002; 23 (09) 1607-1610
    PubMedGoogle Scholar
  • 107 Ruggieri M, Gabriele AL, Polizzi A. , et al. Natural history of neurofibromatosis type 2 with onset before the age of 1 year. Neurogenetics 2013; 14 (02) 89-98
    CrossrefPubMedGoogle Scholar
  • 108 Ruggieri M, Polizzi A, Spalice A. , et al. The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features. Clin Genet 2015; 87 (05) 401-410
    CrossrefPubMedGoogle Scholar
  • 109 Ruggieri M, Praticò AD, Evans DGE. Diagnosis, management and new therapeutic options in childhood neurofibromatosis type 2 and related Forms. Semin Pediatr Neurol 2015; 22 (04) 240-258
    CrossrefPubMedGoogle Scholar
  • 110 Ruggieri M, Praticò AD, Serra A. , et al. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies. Acta Otorhinolaryngol Ital 2016; 36 (05) 345-367
    PubMedGoogle Scholar
  • 111 Caltabiano R, Magro G, Polizzi A. , et al. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas. Childs Nerv Syst 2017; 33 (06) 933-940
    CrossrefPubMedGoogle Scholar
  • 112 Ruggieri M, Iannetti P, Clementi M. , et al. Neurofibromatosis type 1 and infantile spasms. Childs Nerv Syst 2009; 25 (02) 211-216
    CrossrefPubMedGoogle Scholar
  • 113 Ruggieri M. Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5). Am J Med Genet 2001; 101 (02) 178-180
    CrossrefPubMedGoogle Scholar
  • 114 Ruggieri M, Huson SM. The neurofibromatoses. An overview. Ital J Neurol Sci 1999; 20 (02) 89-108
    CrossrefPubMedGoogle Scholar
  • 115 Ruggieri M, Pavone P, Polizzi A. , et al. Ophthalmological manifestations in segmental neurofibromatosis type 1. Br J Ophthalmol 2004; 88 (11) 1429-1433
    CrossrefPubMedGoogle Scholar
  • 116 Ruggieri M, Polizzi A. Segmental neurofibromatosis. J Neurosurg 2000; 93 (03) 530-532
    PubMedGoogle Scholar
  • 117 Ruggieri M. Familial hypomelanosis of ito: implications for genetic counselling. Am J Med Genet 2000; 95 (01) 82-84
    CrossrefPubMedGoogle Scholar
  • 118 Ruggieri M, Magro G, Ruggieri M, Polizzi A. Tumors and hypomelanosis of Ito. Arch Pathol Lab Med 2001; 125 (05) 599-601
    PubMedGoogle Scholar
  • 119 Ruggieri M, Mastrangelo M, Spalice A. , et al. Bilateral (opercular and paracentral lobular) polymicrogyria and neurofibromatosis type 1. Am J Med Genet 2011; 155 A (03) 582-585
    PubMedGoogle Scholar
  • 120 Pavone P, Praticò AD, Ruggieri M, Falsaperla R. Hypomelanosis of Ito: a round on the frequency and type of epileptic complications. Neurol Sci 2015; 36 (07) 1173-1180
    CrossrefPubMedGoogle Scholar
  • 121 Michael GA, Poretti A, Huisman TA. Neuroimaging findings in encephalocraniocutaneous lipomatosis. Pediatr Neurol 2015; 53 (05) 462-463
    CrossrefPubMedGoogle Scholar
  • 122 Toelle S, Poretti A, Scheer I, Huisman T, Boltshauser E. Bannayan-Riley-Ruvalcaba syndrome with progressive spinal epidural lipomatosis. Neuropediatrics 2012; 43 (04) 221-224
    Article in Thieme ConnectPubMedGoogle Scholar
  • 123 Alfonso I, Lopez PF, Cullen Jr RF, Martin-Jimenez R, Bejar RL. Spinal cord involvement in encephalocraniocutaneous lipomatosis. Pediatr Neurol 1986; 2 (06) 380-384
    CrossrefPubMedGoogle Scholar
  • 124 Loggers HE, Oosterwijk JC, Overweg-Plandsoen WC, van Wilsem A, Bleeker-Wagemakers EM, Bijlsma JB. Encephalocraniocutaneous lipomatosis and oculocerebrocutaneous syndrome. A differential diagnostic problem?. Ophthalmic Paediatr Genet 1992; 13 (03) 171-177
    PubMedGoogle Scholar
  • 125 Brassesco MS, Valera ET, Becker AP. , et al. Low-grade astrocytoma in a child with encephalocraniocutaneous lipomatosis. J Neurooncol 2010; 96 (03) 437-441
    CrossrefPubMedGoogle Scholar
  • 126 Phi JH, Park SH, Chae JH, Wang KC, Cho BK, Kim SK. Papillary glioneuronal tumor present in a patient with encephalocraniocutaneous lipomatosis: case report. Neurosurgery 2010; 67 (04) E1165-E1169
    CrossrefPubMedGoogle Scholar
  • 127 Blaney SM, Kun LE, Hunter J. , et al. (2006) Tumors of the central nervous system. In: Pizzo PA, Poplack DG. , eds. Principles and Practice of Pediatric Oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2006: 786-864
    Google Scholar
  • 128 Bieser S, Reis M, Guzman M. , et al. Grade II pilocytic astrocytoma in a 3-month-old patient with encephalocraniocutaneous lipomatosis (ECCL): case report and literature review of low grade gliomas in ECCL. Am J Med Genet A 2015; 167A (04) 878-881
    CrossrefPubMedGoogle Scholar
  • 129 Valera ET, Brassesco MS, Scrideli CA. , et al. Are patients with encephalocraniocutaneous lipomatosis at increased risk of developing low-grade gliomas?. Childs Nerv Syst 2012; 28 (01) 19-22
    CrossrefPubMedGoogle Scholar
  • 130 Koti K, Bhimireddy V, Dandamudi S, Gunnamreddy R. Encephalocraniocutaneous Lipomatosis (Haberl and syndrome): a case report and review of literature. Indian J Dermatol 2013; 58 (03) 232-234
    CrossrefPubMedGoogle Scholar
  • 131 Roszkowski M, Dabrowski D. [Encephalo-cranio-cutaneous lipomatosis (ECCL)— Haberland syndrome. A case report with review of the literature] [Article in Polish]. Neurol Neurochir Pol 1997; 31 (03) 607-613
    PubMedGoogle Scholar
  • 132 Pregowska K, Jurkiewicz E, Miszczak-Knecht M, Turska-Kmiec A, Bieganowska K. Persistent multifocal atrial tachycardia in infant with encephalocraniocutaneous lipomatosis: a case report. Eur J Pediatr 2014; 173 (12) 1577-1580
    CrossrefPubMedGoogle Scholar
  • 133 Fukaya R, Ozaki M, Kamamoto D. , et al. Significant antitumor response of disseminated glioblastoma to bevacizumab resulting in long-term clinical remission in a patient with encephalocraniocutaneous lipomatosis: A case report. Mol Clin Oncol 2016; 5 (04) 417-421
    CrossrefPubMedGoogle Scholar